Skip to content

Howard W Robin, President & CEO at Nektar Therapeutics, sold NKTR on Jun 16, 2026

Data as of Oct 27

▼ SELL$285K4,697 shares at $60.71Howard W Robin President & CEONKTR Nektar Therapeutics
Watch NKTR
Traded
Jun 16, 2026
Disclosed
Jun 18, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Howard W Robin, President & CEO at Nektar Therapeutics, sold NKTR on Jun 16, 2026TRADEDDISCLOSED
NKTRSimilar stocks (XLV — its sector index fund), rebased to NKTR's price on the disclosure day
NKTR since disclosure
−37.7%
after the sale
Similar stocks (XLV) since disclosure
+19.9%
XLV — its sector index fund

Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$277Kdisclosed Jun 18 · filed 1 day after the trade
  2. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$334Kdisclosed Jun 18 · filed 1 day after the trade
  3. ▼ SELLHoward W Robin President & CEONKTR Nektar Therapeutics$318Kdisclosed Jun 18 · filed 2 days after the trade

See every trade on NKTR →